PlainRecalls
FDA Drug Moderate Class II Terminated

Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 50111-647-01, UPC 3 50111-647-01 5.

Reported: May 7, 2014 Initiated: February 12, 2014 #D-1281-2014

Product Description

Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 50111-647-01, UPC 3 50111-647-01 5.

Reason for Recall

Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
72,356 bottles
Distribution
Nationwide and Puerto Rico
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 50111-647-01, UPC 3 50111-647-01 5.. Recalled by Teva Pharmaceuticals USA. Units affected: 72,356 bottles.
Why was this product recalled?
Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 7, 2014. Severity: Moderate. Recall number: D-1281-2014.